The clinical and genetic features of Huntington disease.
about
Levodopa-Induced Dyskinesia Is Related to Indirect Pathway Medium Spiny Neuron Excitotoxicity: A Hypothesis Based on an Unexpected FindingPossible involvement of self-defense mechanisms in the preferential vulnerability of the striatum in Huntington's diseaseEffects of deletion of mutant huntingtin in steroidogenic factor 1 neurons on the psychiatric and metabolic phenotype in the BACHD mouse model of Huntington diseasePlants and phytochemicals for Huntington's diseaseIdentification of a post-translationally myristoylated autophagy-inducing domain released by caspase cleavage of huntingtin.Presentation and care of a family with Huntington disease in a resource-limited community.Pulmonary function in patients with Huntington's diseaseExamination of Huntington's disease in a Chinese familyEffect of enhanced voluntary physical exercise on brain levels of monoamines in Huntington disease miceStriatal neurons expressing full-length mutant huntingtin exhibit decreased N-cadherin and altered neuritogenesis.Identification of binding sites in Huntingtin for the Huntingtin Interacting Proteins HIP14 and HIP14LChanges in BiP availability reveal hypersensitivity to acute endoplasmic reticulum stress in cells expressing mutant huntingtin.Progressive Impairment of Lactate-based Gluconeogenesis in the Huntington's Disease Mouse Model R6/2Characterising Upper Limb Movements in Huntington's Disease and the Impact of Restricted Visual Cues.Is There an Association of Physical Activity with Brain Volume, Behavior, and Day-to-day Functioning? A Cross Sectional Design in Prodromal and Early Huntington Disease.Development of the Huntington disease work function scaleExpression of mutant huntingtin in leptin receptor-expressing neurons does not control the metabolic and psychiatric phenotype of the BACHD mouseStrategies used by teens growing up in families with Huntington disease.Huntington disease in the South African population occurs on diverse and ethnically distinct genetic haplotypesDevelopment of the HD-Teen Inventory.Progression of motor subtypes in Huntington's disease: a 6-year follow-up study.Therapeutic applications of antibodies in non-infectious neurodegenerative diseasesWhat monozygotic twins discordant for phenotype illustrate about mechanisms influencing genetic forms of neurodegeneration.Two decades of Huntington disease testing: patient's demographics and reproductive choices.Palmitoylation and depalmitoylation defects.Evolving Motivations: Patients' and Caregivers' Perceptions About Seeking Myotonic Dystrophy (DM1) and Huntington's Disease Care.Huntington's Disease: Pathogenic Mechanisms and Therapeutic Targets.Ethical aspects of a predictive test for Huntington's Disease: A long term perspective.Characterization of a rat model of Huntington's disease based on targeted expression of mutant huntingtin in the forebrain using adeno-associated viral vectors.Ethical aspects of undergoing a predictive genetic testing for Huntington's disease.Better global and cognitive functioning in choreatic versus hypokinetic-rigid Huntington's disease.Participants at the Leiden Site of the REGISTRY Study: A Demographic Approach.Impact of Huntington Disease Gene-Positive Status on Pre-Symptomatic Young Adults and Recommendations for Genetic Counselors.Motor dysfunction influence on executive functioning in manifest and premanifest Huntington's disease.Respiratory muscle training on pulmonary and swallowing function in patients with Huntington's disease: a pilot randomised controlled trial.
P2860
Q26752867-05C580FB-AC19-4D50-AA2D-F680FF9B6E81Q27011417-4F951F21-4F14-4861-9055-847E5940BBC6Q27346849-60724110-D9E5-4C31-A23D-98477E97C692Q28661435-552EC98A-7D9C-4D72-96A8-4FB1688DF582Q30578636-0ED991A5-062D-484C-950E-C83727D99CD1Q33556293-1C7BED93-3BFE-4F4F-BA3A-10A25CF12E91Q33693989-F79D4650-CF78-410D-B767-596C1B268DBAQ34095823-3D965791-AC04-415A-BF94-409643A7EEBFQ34135360-AEBD6B1E-A7B5-4BF8-B8CD-A28B9E80240AQ34994813-4CC7F093-8448-4299-B9BB-1059CFA4AF17Q35126285-AF091974-F79A-4E02-B8DB-E46822CE7853Q35227496-39659A24-397F-4CE3-837F-3FCE0BFCCF8AQ35660733-EF25F7CD-2491-4099-927E-801C0D460512Q35738853-5925C610-BF3E-4C6D-8E57-A08BC5B31484Q36183886-1F122ECF-3132-4DA9-9CA5-BB41DD867439Q36303727-347BDF9F-84F8-4FF2-83A6-6E073750419BQ36459384-A7B38CEE-3CFD-481D-93F0-533AC578F16FQ37138372-D203A253-48A5-47DD-AB53-C8BB8E22ACC3Q37186056-6F624696-194A-4965-9FE1-2CE3234251ABQ37250319-AB317535-AF57-4727-86C2-0F3688FF9D89Q37284637-4ED993B3-2275-4F71-A37B-DF703E78AF9FQ37862785-EF4BA243-395F-4E31-BBB0-C2BC81AB54A8Q37943395-5A7EEF7F-F40F-42E7-BE25-C7CC93500E8AQ38109547-3C2DF3E2-845C-4EC5-BD67-17FCD12A6599Q38236849-2FE31081-3008-4140-9C06-B7240EC90A15Q38629175-2E7CA4A7-DC21-418B-B0B2-1E1023CA898CQ38663090-3EF22E07-54A1-49B2-AC35-6120EE85BED4Q39015525-17AFDB51-4846-456F-A4A1-C5FE44D90547Q44832011-B3E1C5B4-C9D0-479B-808C-924D3ECBCEF5Q45289680-4FD4DDF7-8E97-45A4-801B-C66FDF54A4ACQ45292387-8F81324D-6023-4D42-BCC7-16A6E612BB89Q45294016-3079D966-F666-48C3-B625-F7C94E337196Q45294608-88B9D984-E8A0-4CFF-A297-0BE367B288CAQ45297368-6C3FB7CC-B946-44B1-A29B-5BD28C492E5EQ45303456-289E30AD-626C-47FA-804B-7009E35868A1
P2860
The clinical and genetic features of Huntington disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 October 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The clinical and genetic features of Huntington disease.
@en
The clinical and genetic features of Huntington disease.
@nl
type
label
The clinical and genetic features of Huntington disease.
@en
The clinical and genetic features of Huntington disease.
@nl
prefLabel
The clinical and genetic features of Huntington disease.
@en
The clinical and genetic features of Huntington disease.
@nl
P2860
P356
P1476
The clinical and genetic features of Huntington disease.
@en
P2093
Aaron Sturrock
P2860
P304
P356
10.1177/0891988710383573
P577
2010-10-05T00:00:00Z